Liste d'obligations internationales ( Toutes )
| Société émettrice | Code ISIN | Devise | Coupon | Montant minimal | Maturité | Prix sur le marché | |
| Merck KGaA | US58933YBE41 | USD | 2.15% | 2 000 USD | 10/12/2031 | 88.466 | |
| Merck KGaA |
US58933YAB11 |
USD | 2.25% | 2 000 USD | 15/01/2016 | Echue | |
| Merck KGaA |
US58933NAW92 |
USD | 0% | 1 000 USD | 22/08/2042 | 99 | |
| Merck KGaA |
US58933YAT29 |
USD | 3.7% | 2 000 USD | 10/02/2045 | 78.079 | |
| Merck KGaA | US806605AH42 | USD | 6.55% | 2 000 USD | 15/09/2037 | 100 | |
| Merck KGaA | US58933YBR53 | USD | 4.55% | 14/09/2032 | 100.84 | ||
| Merck KGaA | US58933YBS37 | USD | 4.95% | 15/09/2035 | 100.74 | ||
| Merck KGaA | US58933YBX22 | USD | 4.15% | 15/03/2031 | 98.94 | ||
| Merck KGaA | US58933YBH71 | USD | 4.05% | 17/05/2028 | 99.9771 | ||
| Merck KGaA | US58933YBM66 | USD | 5% | 17/05/2053 | 100 | ||
| Merck KGaA | US58933YBN40 | USD | 5.15% | 17/05/2063 | 86.992 | ||
| Merck KGaA | US58933YBP97 | USD | 3.85% | 15/09/2027 | 99.593 | ||
| Merck KGaA | US58933YBQ70 | USD | 4.15% | 15/09/2030 | 100 | ||
| Merck KGaA | US58933YBY05 | USD | 4.45% | 04/12/2032 | 100 | ||
| Merck KGaA | US58933YBZ79 | USD | 4.75% | 04/12/2035 | 100 | ||
| Merck KGaA | US58933YCB92 | USD | 5.55% | 04/12/2055 | 100 | ||
| Merck KGaA | US58933YCC75 | USD | 5.7% | 04/12/2065 | 99.29 | ||
| Merck KGaA | US58933YBK01 | USD | 4.5% | 17/05/2033 | 100 | ||
| Merck KGaA | XS2825486074 | EUR | 3.7% | 30/05/2044 | 92.64 | ||
| Merck KGaA | XS2825486231 | EUR | 3.75% | 30/05/2054 | 87.32 | ||
| Merck KGaA | XS2825485852 | EUR | 3.5% | 30/05/2037 | 97.39 | ||
| Merck KGaA | XS2825485183 | EUR | 3.25% | 30/05/2032 | 99.41 | ||
| Merck KGaA | US79584E1073 | USD | 4.3% | 2 000 USD | 22/05/2028 | 100 | |
| Merck KGaA | US83304A1060 | USD | 4.3% | 2 000 USD | 22/05/2028 | 100 | |
| Merck KGaA | BRZAMPACNOR5 | USD | 4.3% | 2 000 USD | 22/05/2028 | 100 | |
| Merck KGaA | CA0342231077 | USD | 4.3% | 2 000 USD | 22/05/2028 | 100 | |
| Merck KGaA | CA64016L1013 | USD | 4.3% | 2 000 USD | 22/05/2028 | 100 | |
| Merck KGaA | CH1132953634 | USD | 4.3% | 2 000 USD | 22/05/2028 | 100 | |
| Merck KGaA | CH1134904635 | USD | 4.3% | 2 000 USD | 22/05/2028 | 100 | |
| Merck KGaA | CH1144246134 | USD | 4.3% | 2 000 USD | 22/05/2028 | 100 | |
| Merck KGaA | CH1149573334 | USD | 4.3% | 2 000 USD | 22/05/2028 | 100 | |
| Merck KGaA | CH1168662265 | USD | 4.3% | 2 000 USD | 22/05/2028 | 100 | |
| Merck KGaA | CY0200252118 | USD | 4.3% | 2 000 USD | 22/05/2028 | 100 | |
| Merck KGaA | INE0DK501011 | USD | 4.3% | 2 000 USD | 22/05/2028 | 100 | |
| Merck KGaA | KR7452260003 | USD | 4.3% | 2 000 USD | 22/05/2028 | 100 | |
| Merck KGaA | SE0018245953 | USD | 4.3% | 2 000 USD | 22/05/2028 | 100 | |
| Merck KGaA | TH0832B10Z14 | USD | 4.3% | 2 000 USD | 22/05/2028 | 100 | |
| Merck KGaA | TH3925010Z13 | USD | 4.3% | 2 000 USD | 22/05/2028 | 100 | |
| Merck KGaA | THB231010018 | USD | 4.3% | 2 000 USD | 22/05/2028 | 100 | |
| Merck KGaA | TW0005388003 | USD | 4.3% | 2 000 USD | 22/05/2028 | 100 | |
| Merck KGaA | IE00BF4NFF94 | USD | 4.3% | 22/05/2028 | 100 | ||
| Merck KGaA | UZ00000001Z7 | USD | 4.3% | 22/05/2028 | 100 | ||
| Merck KGaA | ARSUPE080774 | USD | 4.3% | 22/05/2028 | 100 | ||
| Merck KGaA | US674599EB53 | USD | 4.3% | 22/05/2028 | |||
| Merck KGaA | FI4000210877 | USD | 4.3% | 22/05/2028 | 100 | ||
| Merck KGaA | IT0000367638 | USD | 4.3% | 22/05/2028 | 100 | ||
| Merck KGaA | LU0198731290 | USD | 4.3% | 22/05/2028 | 100 | ||
| Merck KGaA | BE6291764536 | USD | 4.3% | 22/05/2028 | 100 | ||
| Merck KGaA | US674599DT91 | USD | 4.3% | 22/05/2028 | |||
| Merck KGaA | US17331AHB08 | USD | 4.3% | 22/05/2028 | 100 | ||
Merck & Co., Inc. is a leading global biopharmaceutical company that discovers, develops, manufactures, and markets a broad range of innovative health solutions across various therapeutic areas.
Merck & Co., Inc. est une importante entreprise pharmaceutique et biotechnologique mondiale spécialisée dans la découverte, le développement et la commercialisation de médicaments et de vaccins innovants.
Merck & Co., Inc. è una multinazionale farmaceutica statunitense che sviluppa, produce e commercializza farmaci e vaccini a livello globale.